City Light Capital
VC Fund
New York, United States
City Light Capital is a VC fund in New York focused on Health Care and Software. City Light is a venture capital firm that invest in impactful companies in the areas of education, safety and care, and the environment.
- Total investments:
- 214
- Last investment:
- Lead investor:
- 7%
- Fund size:
- $57M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries City Light Capital invests in
Stages City Light Capital invests in
Countries City Light Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.2M–$8M
- Series A
- $4M–$27M
- Series B
- $8.5M–$60M
Investment Focus
Industry
- Health Care 60 (28%)
- Software 33 (15%)
- Artificial Intelligence 24 (11%)
- Wellness 23 (11%)
- Information Technology 21 (10%)
Stage
- Seed 106 (50%)
- Series A 36 (17%)
- Series B 16 (7%)
- Pre-Seed 11 (5%)
- Funding Round 9 (4%)
Country
- United States 152 (71%)
- Canada 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Daniel Katzman
Investor, Analyst
|
Investor, Analyst | Total investments: 0 | Find email | |
Grace Cushman
Vice President of Operations
|
Vice President of Operations | Total investments: 0 | Find email | |
Jeff Rinehart
Partner
|
Partner | Total investments: 10 | Find email | |
Joshua Cohen
Founder & Partner
|
Founder & Partner | Total investments: 22 | Find email | |
Rohan Nair
Analyst
|
Analyst | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Xage Security
|
Xage Security is an information technology company that offers blockchain-protected security platform for Industrial IoT. | $15M / Venture - Series Unknown / Mar 18, 2026 | |
Salvo Health
|
Salvo is emerging as the leader in helping GI providers leap into a hybrid-care vision of the future of medicine, providing brick & mortar clinics with an easy to implement continuous care platform that saves time, increases revenue and improves patient outcomes.The company has announced agreements with 771 GI’s, representing 15% of allindependent GI’s in the US, to deploy wraparound care for their clinic patients. Included in its customers are five of the largest GI practices in the country, together seeing over 1.1 million GI patients a year. Salvo provides the tech and care delivery for modern, interdisciplinary care to treat chronic conditions that have surged in cost and prevalence: --IBS and IBD (over 40M affected) -- GERD and Celiac (over 50M affected) --MASH/MASLD, what was previously called “fatty liver disease” (over 80M) --Obesity (over 100M) The care benefits patients (76% of patients reported improved symptoms, five accepted medical conference abstracts on outcomes), generates incremental profit for practices (over $2M EBITDA improvement for a 100 GI practice), and reduces total healthcare costs (79% drop in GI-related ER utilization). | $8.5M / Series A / Jan 22, 2026 | |
|
Salvo Health
|
Salvo is emerging as the leader in helping GI providers leap into a hybrid-care vision of the future of medicine, providing brick & mortar clinics with an easy to implement continuous care platform that saves time, increases revenue and improves patient outcomes.The company has announced agreements with 771 GI’s, representing 15% of allindependent GI’s in the US, to deploy wraparound care for their clinic patients. Included in its customers are five of the largest GI practices in the country, together seeing over 1.1 million GI patients a year. Salvo provides the tech and care delivery for modern, interdisciplinary care to treat chronic conditions that have surged in cost and prevalence: --IBS and IBD (over 40M affected) -- GERD and Celiac (over 50M affected) --MASH/MASLD, what was previously called “fatty liver disease” (over 80M) --Obesity (over 100M) The care benefits patients (76% of patients reported improved symptoms, five accepted medical conference abstracts on outcomes), generates incremental profit for practices (over $2M EBITDA improvement for a 100 GI practice), and reduces total healthcare costs (79% drop in GI-related ER utilization). | $8.5M / Series A / Jan 22, 2026 | |
Benchmark Health
|
Benchmark Health is a digital healthcare company that offers a platform matching individuals with appropriate mental health services and support. It leverages data-driven tools to guide users through therapy, psychiatry and peer support pathways. The company integrates treatment networks with outcome tracking to enable personalised care. Itcollaborates with clinics and care providers to streamline access and coordination of mental health resources. | Seed / Jan 01, 2026 | |
Clarity Pediatrics
|
Clarity Pediatrics is reimagining pediatric chronic care, starting with ADHD. Nearly 10% of American children are diagnosed with ADHD, and for parents it can feel impossible to get the right care. We are building a virtual pediatric ADHD clinic that delivers trusted care to all families. Our new clinical model is tech-enabled, backed by the bestscience, and has the potential to deliver exceptional health outcomes to transform a child’s trajectory. | $14.5M / Series A / Dec 17, 2025 | |
|
Auxira Health
|
Auxira Health is committed to providing virtual practice extensions that seem like a natural extension of your team, bringing order to the chaos of modern healthcare. | $7.8M / Seed / Dec 15, 2025 | |
Affect
|
Affect Therapeutics is using mobile technology to revolutionize stimulant addiction recovery. | $26M / Series B / Sep 23, 2025 | |
Birches Health
|
Birches Health provides therapy and support for those struggling with behavioral and process addictions. | $10M / Series A / Sep 16, 2025 | |
WattCarbon
|
WattCarbon develops decarbonization measurement and verification tools to track the carbon intensity of building energy use. The company was founded in 2021 with its headquarters in Lafayette, California. | Seed / Jul 17, 2025 | |
Atomic Canyon
|
The Atomic Canyon AI application is intended for use by nuclear power plants, next-generation reactor builders, and government and national laboratories. | $7M / Seed / May 28, 2025 | |
| See all 214 investments → | |||
Co-Investors
Alumni Ventures
17 deals together
Human Ventures
11 deals together
AlleyCorp
9 deals together
Plug and Play
9 deals together
Gaingels
8 deals together
JAM Fund
8 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does City Light Capital invest in?
City Light Capital invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 214 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is City Light Capital's check size?
City Light Capital typically joins rounds of $1.2M–$8M at Seed, $4M–$27M at Series A and $8.5M–$60M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds City Light Capital participates in.
How do I contact City Light Capital?
Public channels for City Light Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at City Light Capital?
The team at City Light Capital includes Daniel Katzman (Investor, Analyst), Grace Cushman (Vice President of Operations) and Jeff Rinehart (Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
